30.20Open30.20Pre Close0 Volume2 Open Interest110.00Strike Price0.00Turnover170.28%IV-4.44%PremiumDec 20, 2024Expiry Date33.59Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9811Delta0.0040Gamma2.27Leverage Ratio-0.0514Theta-0.0061Rho-2.23Eff Leverage0.0035Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet